Recovery of the cardiac adrenergic nervous system after long-term β-blocker therapy in idiopathic dilated cardiomyopathy: Assessment by increase in 123I-metaiodobenzylguanidine uptake

Journal of Nuclear Medicine

Volumn 42, Issue 1, 2001, Pages 49-54

  Lotze, U ^a   Kaepplinger, S ^a   Kober, A ^a   Richartz, B M ^a   Gottschild, D ^a   Figulla, H R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

blocker therapy; 123I MIBG; Cardiac adrenergic activity; Idiopathic dilated cardiomyopathy

Indexed keywords

(3 IODOBENZYL)GUANIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; IODINE 123; METOPROLOL;

ADOLESCENT; ADRENERGIC ACTIVITY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DRUG EFFECT; DRUG UPTAKE; FEMALE; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MALE; NEUROTRANSMITTER RELEASE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RISK ASSESSMENT;

3-IODOBENZYLGUANIDINE; ADRENERGIC BETA-ANTAGONISTS; CARDIOMYOPATHY, DILATED; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035137672     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure
2. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
3. Predicting survival for an individual with congestive heart failure using plasma norepinephrine concentration
4. Cardiac sympathetic nervous activity in congestive heart failure: Evidence for increased neuronal nompinephrine release and preserved neuronal uptake
5. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure
6. Uptake of catecholamines by human cardiac muscle in vitro
7. Evidence for reduction of norepinephrine uptake sites in the failing human heart
8. Cardiac sympathetic nerve function in congestive heart failure
9. β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanism
10. Mechanisms of membrane-receptor regulation
11. β-Adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content
12. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man
13. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine
14. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants
15. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
16. A randomized trial of β-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS)
17. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group
18. The cardiac insufficiency bisoprolol study II (CIBIS II)
19. Effect of metoprolol CR/XL in chronic heart failure: MetoproloI CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
20. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy
21. Cardiac adrenergic receptor effects of carvedilol
22. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart
23. Clinical effects of bisoprolol in congestive heart failure due to dilated cardiomyopathy
24. The β-blocking agents metoprolol and carvedilol affect cardiac adrenergic drive differently in subjects with heart failure from dilated cardiomyopathy [abstract]
25. Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: A new approach using the left ventricular cavity and a blood sample as a reference
26. Myocarditis: A histopathologic definition and classification
27. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiography measurements
28. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms
29. Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy
30. Increased myocardial [123-I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure
31. Sympathoinhibitory responses to digitalis glycosides in heart failure: Direct evidence from sympathetic nerve recordings
32. Myocardial catecholamine concentrations in dilated cardiomyopathy and heart failure of different origins
33. 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy
34. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of β-blocker therapy in patients with dilated cardiomyopathy
35. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy
36. Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle: Influence of immobilization stress and inhibition of the renin-angiotensin system
37. Comparison between iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability for the assessment of cardiac sympathetic activity in mild to moderate heart failure
38. Dual-tracer assessment of coupling between cardiac sympathetic neuronal function and downregulation of receptors during development of hypertensive heart failure of rats
39. Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart